ICMR - NIRBI


ICMR - National Institute for Research
in Bacterial Infections

आईसीएमआर - राष्ट्रीय जीवाणु संक्रमण अनुसंधान संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases

BETI BACHAO BETI PADHAO
G20

  English   |   हिंदी           

NICED : Scientists

  1. NICED
  2. Scientists
Dr. Saibal Das

Dr Saibal Das


 

General Information
Name Dr Saibal Das
Designation Scientist D
Division  
Specialization  
Date of joining ICMR  
Date of joining the present post  
Phone: +91 80724 86512
Email : saibal.das@icmr.gov.in, saibaldas123@gmail.com
Institute: :Indian Council of Medical Research - National Institute for Research in Bacterial Infections (ICMR-NIRBI)
MBBS: Nil Ratan Sircar Medical College & Hospital, Kolkata (2005-2011)
MD (Pharmacology): CMC, Vellore (2014-2017)
DM (Clinical Pharmacology): JIPMER, Puducherry (2017-2020)

Profile

Research Experience

Sr. No. Role / Position Institution / Organization Duration Research Focus / Key Contributions
1 Scientist D (Medical) ICMR-NIRBI, Kolkata Apr 2025 - Present Leading clinical research projects, evidence synthesis, training, and administrative responsibilities
2 Scientist D (Medical) ICMR-Centre for Ageing and Mental Health, Kolkata Apr 2022 - Apr 2025 Conducted research on ageing, pharmacoepidemiology, clinical pharmacology, and medication safety
3 Scientist D (Medical) ICMR Headquarters, New Delhi Jul 2021 - Apr 2022 Central coordination of national-level research projects, clinical trials, and drug development
4 Regional Medical Advisor GSK Pharmaceuticals Ltd., Mumbai Aug 2020 - Jul 2021 Managed medical & regulatory affairs, supervised Phase IV trials, pharmacovigilance, and bioequivalence studies
5 Senior Resident (Academic) Dept. of Clinical Pharmacology, JIPMER, Puducherry Jul 2017 - Jul 2020 Conducted clinical trials, patient care services, therapeutic drug monitoring, and teaching
6 Post Graduate Registrar Dept. of Pharmacology &Clinical Pharmacology, CMC, Vellore Apr 2014 - Mar 2017 Engaged in pre-clinical & clinical research, drug safety, and pharmacogenomics
7 Research Student Calcutta School of Tropical Medicine, Kolkata Mar - Oct 2011 Pre-clinical research in pharmacology and tropical medicine
8 Medical Officer (NRHM) Nalmuri Block Primary Health Centre, WB Dec 2012 - Mar 2014 Conducted field-level clinical research while providing primary care
9 Resident Medical Officer Repose Clinic & Research Centre Pvt. Ltd., Kolkata 2011-2012 Patient care services with research contributions in clinical pharmacology
 
10 Junior Resident NRS Medical College & Hospital, Kolkata Jul 2011 - Mar 2012 Emergency care, exposure to clinical pharmacology applications in real-world settings

Research Interests

My research primarily focuses on the rational and evidence-based use of medicines across diverse populations. I am deeply engaged in designing and conducting clinical trials, observational studies, and systematic reviews to generate high-quality real-world evidence on the efficacy, effectiveness, and safety of drugs. My interests extend to pharmacogenomics and precision medicine, aiming to optimize individualized therapy. I actively contribute to antibiotic stewardship, pharmacovigilance, and drug development initiatives. By integrating clinical pharmacology with public health, I aim to generate real-world evidence that informs guidelines and improves antimicrobial use for better patient outcomes. Additionally, I explore health systems and policy-related aspects of medicine use, with a strong commitment to improving patient safety, ensuring equitable access, and advancing translational research for public health impact.

Memberships

National Societies

  1. Indian Public Health Association (IPHA)
  2. Epidemiology Foundation of India (EFI)
  3. Forum for Ethics Review Committees in India (FERCI)
     

International Societies

  1. WHO Global Patient Safety Network
  2. International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  3. International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
  4. International Society for Pharmacoepidemiology (ISPE)
  5. International Headache Society (IHS)
     

Awards

National Awards

  1. Two Global Recognitions for Scientific Engagement, GSK Pharmaceutical Ltd., India (2021)
  2. Winner, Maiden IJME Young Bioethicist and Changemaker Award, IJME and FMES, Mumbai (2019)
  3. ISRPT-JIPMER Medal for Best Poster Presentation, 11th ISRPTCON, Kolkata (2019)
  4. ISRPT Medal for Best Oral Presentation, 11th ISRPTCON, Kolkata (2019)
  5. Award for Best Critical Appraisal and Quiz (Runners-up), 2nd EBCCON, Chennai (2019)
  6. Second Prize, Research Presentation, 4th Research Day, JIPMER, Puducherry (2019)
  7. Rabindra Mandanha Prize for Best PG Research Paper (Basic Science), CMC Vellore (2016)
  8. Second Prize, Three Minute Thesis Competition, CMC Vellore (2016)
  9. Dr. Asim Kumar Biswas Memorial Scholarship Award, NRS Medical College and Hospital, Kolkata (2011)
  10. Runners-up, 22nd Indian Acad€emy of Pediatrics Quiz for Undergraduates (2009)
  11. National Certificate of Merit, School-leaving Examination, Government of West Bengal (2006)

International Awards

  1. Long-Term Fellowship Abroad, Department of Health Research, MoHFW, Govt. of India (2025)
  2. Travel Grant - 19th Congress of the International Headache Society (IHS), Dublin, Ireland (2019) (£1,000)
  3. Travel Grant - 15th International Congress of IATDMCT, Kyoto, Japan (2017) (USD 2,000)
  4. Travel Grant - 33rd ICPE, Montreal, Canada (2017) (USD 2,200)
  5. Travel Grant - 10th ACPE, Brisbane, Australia (2017) (AUD 1,720)
  6. Travel Grant - 24th ISCOMS, Groningen, Netherlands (2017) (€550)
  7. Travel Grant - 7th ISPOR Asia-Pacific Conference, Singapore (2016) (USD 2,500)

 

Projects

As Principal investigator

  1. Technical Resource Centre (Centre for Evidence for Guidelines) [Funding Agency: Department of Health Research (DHR)(2024-2029)]
  2. Clinical Utility and Cost-Effectiveness of Pharmacogenomics-Assisted Treatment in Treatment-Resistant Schizophrenia [Funding Agency: ICMR(2024-2027)
  3. Pharmacogenomics-Assisted Schizophrenia Management: A Hybrid Type 2 Effectiveness-Implementation Study [Funding Agency: ICMR(2023-2026)]
  4. Efficacy of Adjunct Probiotics in Elderly Patients with Moderate Unipolar Depression: A Randomized Controlled Trial [Funding Agency: DHR(2023-2025)]
  5. Burden, Risk Factors, and Service Needs of People with Non-Fatal Opioid Poisoning [Funding Agency: ICMR(2023-2025)]
  6. Facilitators and Barriers for Uptake of COVID-19 Vaccine Precaution Dose
    [Funding Agency: ICMR (2022-2023)]
     

As Co-investigator

  1. Phase IIa RCT on Oxfendazole as a Macro-filaricidal Drug [Funding Agency: Drugs for Neglected Diseases initiative (DNDi) (2024-2026)]
  2. Evaluation of Influenza and Pneumococcal Vaccination in the Elderly - An RCT [Funding Agency: ICMR(2024-2026)]
  3. Mental Health Issues among Mine Workers of Eastern Coalfields Ltd., West Bengal [Funding Agency: ICMR(2023-2025)]
  4. Development and Application of Frailty Management Model for Elderly
    [Funding Agency: ICMR (2024-2026)]
  5. Role of Stem Cells in ARDS - A Systematic Review and Meta-analysis
    [Funding Agency: DHR(2023)]
  6. Evaluation of the Efficacy of Pilex Forte® in Common Anorectal Conditions (Clinical Research Coordinator - CRC) [Funding Agency: The Himalaya Drug Company(2018-2019)]
  7. Lithium Prophylaxis in Early-Onset Bipolar Disorder: A Descriptive Study
    [Funding Agency: SERB(2017-2020)]
  8. Association of Vitamin D Level with Vascular Functions in T2DM Patients with CKD [Funding Agency: Endocrine Society of TN & Puducherry(2019-2020)]
     

Students

Nil

Travel to foreign countries

  1. Long-Term Fellowship Abroad, Department of Health Research, MoHFW, Govt. of India (2025)
  2. 19th Congress of the IHS, Dublin, Ireland (2019)
  3. 15th International Congress of IATDMCT, Kyoto, Japan (2017)
  4. Travel Grant - 33rd ICPE, Montreal, Canada (2017)
  5. Travel Grant - 7th ISPOR Asia-Pacific Conference, Singapore (2016)
     

Publications

2025

  1. Das S,* Sarkar S, Bhowmik K, Mukherjee S, Saha I, Basu A, Roy A, Rao R, Sarkhel S, Neogi R, Bhargava S, Paramanik M, Ghosh A, Mandal S, Mondal S, Sen S, Mondal M, Khatun Y, Saha A, Chakrabarti A. Risk of overdose among opioid users in Kolkata: A cross-sectional study. Indian J Psychol Med. 2025 (In Press).
  2. Das S,*Gnanavel P, Smanla S, Saikia AM, Mishra S, Khare S, Murugan SA, Prakash VN, Roychoudhury P, Ahmad I, Diwan V, Rajesh J, Kumar KS, Kishore J, Srivastava N, Yasmin S, Nasrin M, Borah R, Basistha MS, Baruah C, Kalita M, Samajdar SS, Cherian JJ, Pathak A, Panda S, Tripathi SK, Lundborg CS. Polypharmacy and self-medication among older adults in Indian urban communities - a cross-sectional study. Sci Rep. 2025;15:4062.
  3. Guin A, Haokip HR, Bandyopadhyay S, Das S, Saha I, Basu A, Bhargava S. Effectiveness of oral bupropion and nortriptyline as an adjunct treatment for reducing the use of smokeless tobacco: a retrospective study from a tobacco cessation clinic in a tertiary care hospital in eastern India. Indian J Public Health. 2025;69(2):185-190.
  4. Xavier AS, Selvarajan S, Das S, Kamalanathan S. Exploring the Association Between Vitamin D and IL-10 in Allergic Parthenium Contact Dermatitis Patients. Cureus. 2025;17(6):e85515.
  5. Bandyopadhyay S, Samajdar SS, Das S. Ulinastatin for the Treatment of Severe Acute Pancreatitis: A Systematic Review and Meta- Analysis. BMC Gastroenterol. 2025 (In Press).
  6. Rehman T, Agrawal R, Ahamed F, Das S, Mitra S, Kumar D, Sethy C, Kanungo S, Bhattacharya D, Pati S. Optimal Dose and Duration of Iron Supplementation for Treating Iron Deficiency Anaemia in Children and Adolescents: A Systematic Review and Meta-analysis. PLoS One. 2025;20(2):e0319068.
  7. Saha I, Majumder J, Bagepally BS, Ray D, Das S, Kalita M, Devaraja M, Velayudhan A, Das D, Paul B, Dey S. Coverage and determinants of mass drug administration against lymphatic filariasis in Southeast Asian regional countries during the end-game strategy: a systematic review and meta-analysis of published articles from January 2019 to March 2025. J Vector Borne Ds. 2025 (In Press).
  8. Math PB, Ravi R, Hakami T, Das S.  Pharmacotherapy for post-stroke cognitive impairment: A review. Stroke Res Treat. 2025;2025:6893801.
  9. Cherian JJ, Poomali A, Mukherjee A, Gupta TM, Medhi B, Mukherjee S, Sankaranarayanan A, Saha N, Gota V, Gudde RS, Pahuja M, Das S, Chatterjee NS, Bose R, Kshirsagar N, Raghuvanshi RS. Increasing early phase clinical trials capacity in India. Commun Med. 2025 Jul 1;5(1):255.

2024

  1. Godbole S, Diwan V, Das S, Reddy MM, Kalyanasundaram M, Rajendran D, Biswas D, Mamulwar M, Tiwari RR, Majumder J, Mishra A, Muthusamy SK, Memeenao M, Gupta N, Gupta S, George LS, Kadale P, Trushna T, Saha I, Alam U, Kathiresan J, Phukan SK, Sane S, Bhowmik K, Yadav GK, Krishnamurthy V, Gogoi P, Padhye K, Kant R, Ghosh P, Kharat M, Kulkarni A. Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India. Front Public Health. 2024;11:1293600.
  2. Das S,* Sarkar S, Bhowmik K, Mukherjee S, Saha I, Basu A, Roy A, Rao R, Sarkhel S, Neogi R, Bhargava S, Paramanik M, Ghosh A, Mandal S, Mondal S, Sen S, Mondal M, Khatun Y, Saha A, Chakrabarti A. Perceptions on treatment utilization and risk of overdose among opioid users in Kolkata: A qualitative study. Indian J Psychol Med. 2024 (In Press).
  3. Sabu ST, Venkatraman S, Cherian JJ, Das S, Pahuja M, Adhikari T, Mukherjee S, Chatterjee NS, Kshirsagar NA. A review of clinical trials registered in India from 2008 to 2022 to describe the first-in-human trials. Perspect Clin Res. 2024.15(1):18-23.
  4. Xaviar S, Girish K, Jagannath B, Das S. Comparativeefficacy and safety of co-amoxiclav, cefpodoxime proxetil, and levofloxacin in patients with acute uncomplicated bacterial tonsillitis. J Family Med Prim Care. 2024;13(12):5570-5574.
  5. Das S, Khare S, Eriksen J, Diwan V, Stålsby Lundborg C, Skender K. Interventions on informal healthcare providers to improve the delivery of healthcare services in low-and middle-income countries: a systematic review. Front Public Health. 2024;12:1456868.
  6. Das S, Kalita M, Makhal M, Devaraja M, Bagepally BS, Cherian JJ, Aadityan R, Bhattacharjee M, Mondal S, Sen S, Mondal M, Basu A, Dutta AK, Saha I, Saha A, Chakrabarti A. Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis. BMC Psychiatry. 2024;24:663
  7. Dasgupta S, Mukherjee S, Das S, Kalita M, Saha I, Bagepally BS, Bagchi C. An insight into the efficacy of Leprosy vaccines across the globe: A Systematic Review & Meta-analysis of the Randomised Controlled Trials. Indian J Med Res. 2024;160(3&$):293-302.
  8. Bandyopadhyay S, Verma P, Samajdar SS, Das S. Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2024;48(6):102373.
  9. Das S, Bagepally BS, Eerike M, Cherian JJ, Dasgupta S, Mathews G, Rao S. Performance in a Balance Test and Prediction of All-Cause Mortality in Community-Dwelling Elderly Ambulatory Individuals: A Systematic Review and Meta-analysis. Res Aging. 2024,46(7-8): 437-448.
  10. Bhargava SS, Das S, Priya H, Mishra D, Shivabasappa S, Sood A, Hazarika CR, Gupta PC, Chakma JK, Swasticharan L, Sinha P, Munish VG, Gupta SR. The Burden and Correlates of Waterpipe (Hookah) Smoking among Adolescents and Youth: A Systematic Review. Subst Use Misuse. 2024;59(1):29-40
  11. Bandyopadhyay S, Samajdar SS, Chaudhuri S, Das S. An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review. Hosp Prac. 2024;52(4-5):123-129.
  12. Basu A, Dutta AK, Bagepally BS, Das S,* Cherian JJ, Roy S, Maurya PK, Saha I, Sukumaran D, Rina K, Mandal S, Sarkar S, Kalita M, Bhowmik K, Saha A, Chakrabarti A. Pharmacogenomics-assisted schizophrenia management: A hybrid type 2 effectiveness-implementation study protocol to compare the clinical utility, cost-effectiveness, and barriers.PLoS One. 2024;19(4):e0300511.

2023

  1. Xavier AS, Goud AC, Das S, Behera SK, Selvarajan S. Influence of Vitamin D Status and IL-10 Gene Promoter Polymorphism (rs1800871) on Plasma IL-10 Levels in Apparently Healthy Individuals from Southern India: A Cross-sectional Study. J Clin Diagn Res. 2023;17(5):GC05-GC09.
  2. Das S, Selvarajan S, Kamalanathan S, Parameswaran S, Zachariah B. A Randomized Double-Blind Placebo-Controlled Trial Evaluating the Efficacy of Oral Cholecalciferol in Improving Renal and Vascular Functions in Vitamin D-Deficient Patients With Type 2 Diabetes Mellitus. J Diet Suppl. 2023;20(1):44-54.
  3. Venkatraman S, Das S, Eerike M, Cherian JJ, Bagepally BS. Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2023;79(11):1453-1463.
  4. Bandyopadhyay S, Das S, Samajdar SS, Joshi SR. Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023;17(10):102849.
  5. Das S, Roy A, Behera SK, Selvarajan S, Kamalanathan S, Sahoo JP, Nair NS. Effects of Vitamin D on Migraine: A Meta-Analysis. Neurol India. 2023;71(4):655-661.
  6. Das S, Bandyopadhyay S, Sawant S, Chaudhuri S. The epidemiological and mycological profile of superficial mycoses in india from 2015 to 2021: A systematic review. Indian J Public Health. 2023;67(1):123-135.
  7. Bandyopadhyay S, Samajdar SS, Das S. Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2023;47(7):102174.
  8. Joshi SR, Das S, Xaviar S, Samajdar SS, Saha I, Sarkar S, Mukherjee S, Tripathi SK, Pal J, Chatterjee N. Efficacy and safety of lobeglitazone, a new Thiazolidinedione, as compared to the standard of care in type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Metab Syndr. 2023;17:102703.
  9. Math PB, Ravi R, Hakami T, Das S, Patel N. Vibrating colon-stimulating capsule to treat chronic constipation: A systematic review. J Med Life. 2023;16(7):1050-1056.
  10. Das S, Samajdar SS, Mukherjee S, Sarkar S, Sen S, Pathak A, Lundborg CS, Selvarajan S, Tripathi SK, Pal J, Chatterjee N, Joshi SR. Ten clinical pharmacological interventions in routine care to ensure better treatment outcomes. Das S, et al. Int J Pharm Prac. 2023;31(4):444-446.
  11. Joshi SR, Das S, Xaviar S, Samajdar SS, Saha I, Sarkar S, Mukherjee S, Tripathi SK, Pal J, Chatterjee N. Letter to the Editor regarding articles on lobeglitazone.Diabetes Metab Syndr. 2023;17:102727.
  12. Das S.* Editorial: Medication safety in COVID-19 management, Volume II. Das S.*Front Pharmacol. 2023;14:1175152.

2022

  1. Samajdar SS, Das S, Sarkar S, Mukherjee S, Pathak A, Stålsby Lundborg C, Saha I, Tripathi SK, Pal J, Chatterjee N, Joshi SR. Association between Polypharmacy and Cardiovascular Autonomic Function among Elderly Patients in an Urban Municipality Area of Kolkata, India: A Record-Based Cross-Sectional Study. Samajdar SS, Das S, et al. Geriatrics (Basel). 2022;7(6):136.
  2. Kamalanathan S, Das S, Srinivasan A, Anandabaskar N, Sahoo J, Selvarajan S. Effect of Vitamin D on arterial stiffness in type 2 diabetes patients with intermediate chronic kidney disease. Int J Diabetes Dev Ctries. 2022;42(1):138-146.
  3. Das S, Tiwari S, Xaviar S. An Audit of the Quality of Reporting and Bias of Studies on Yoga in Epilepsy. Neurol India. 2022;70(5):2009-2014.
  4. Bhowmick S, Banerjee S, Das S, Nath A, Kundu D, Das A, Das N, Ray K, Purkayastha SK. Awareness and understanding among patients about patient safety in India: a cross-sectional questionnaire-based study. J Patient Saf Risk Manag. 2022;27(1):21-25.
  5. Cherian JJ, Eerike M, Bagepally BS, Das S,* Panda S. Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis. Front Pharmacol. 2022;13:1004308.
  6. Das S.* Editorial: Medication Safety in COVID-19 Management. Front Pharmacol. 2022;13:940307.

2020

  1. Das S, Xaviar S. Calculation of the fragility index of randomized controlled trials in epilepsy published in twelve major journals. Epilepsy Res. 2020;159:106258.
  2. Ghosh A, Das S, Behera SK, Ramakrishnan K, Selvarajan S, Kandasamy P, Nair NS. Atomoxetine Does Not Improve Complex Attention in Idiopathic Parkinson's Disease Patients with Cognitive Deficits: A Meta-Analysis. Parkinson's Dis. 2020:4853590.
  3. Das S, Bhowmick S, Tiwari S, Sen S. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Clin Drug Investig. 2020;40(7):591-601.
  4. Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Int J Rheumat Dis. 2020;23(5):613-619.
  5. Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumat Inthttps://doi.org/10.1007/s00296-020-04639-9.2020;40(1):1539-1554.
  6. Das S, Behera SK, Xavier AS, Selvarajan S. Prophylactic Use of Steroids and Antibiotics in Acute Hydrocarbon Poisoning in Children. J Pharm Pract. 2020;33(1):90-95.
  7. Maiti T, Das S, Ramasamy A, Stanley Xavier A, Kumar Behera S, Selvarajan S. An overview on medication-assisted treatment (MAT) for opioid dependence. J Opioid Manag. 2020;16(2):141-149.
  8. Das S, Behera SK, Ramakrishnan K, Ganesapandian M, Munuswamy H, Selvarajan S. A complex interaction between antitubercular treatment and acenocoumarol. Eur J Clin Pharmacol. 2020;76(1):133-135.
  9. Maiti T, Bhattacharya D, Das S.* Pain or fear of pain: which incapacitates us more? A complex opioid story. Pain Manag. 2020;10(5):279-281
  10. Das S,* Maiti T. Lysergic acid diethylamide as an analgesic agent in patients with terminal illnesses. Pain Manag. 2020;10(1):9-12.

2019

  1. Rajaram M, Selvarajan S, Neelamegan R, Kamalanathan S, Gunaseelan V, Xavier AS, Das S, Karthikeyan V, Saka V, Chandrasekaran A. Effects of genetic polymorphisms in Vitamin D metabolic pathway on Vitamin D level and asthma control in South Indian patients with bronchial asthma. Lung India. 2019;36(6):483-491.
  2. Das S, Behera SK, Xavier AS, Dharanipragada S, Selvarajan S. Are drug-drug interactions a real clinical concern? Perspect Clin Res. 2019;10(2):62-66
  3. Selvarajan S, Manohar H, Das S, Sakkarabani P, Kandasamy P. Lithium prophylaxis in early-onset Bipolar disorder: a descriptive study. Asian J Psychiatr. 2019;44:172-174.
  4. Behera SK, Das S, Xavier AS, Selvarajan S, Anandabaskar N. Indian Council of Medical Research's National Ethical Guidelines for biomedical and health research involving human participants: The way forward from 2006 to 2017. Perspect Clin Res. 2019;10(3):108-114.
  5. Das S, Ramakrishnan K, Behera SK, Ganesapandian M, Xavier AS, Selvarajan S. Hepatitis B Vaccine and Immunoglobulin: Key Concepts. J Clin Transl Hepatol. 2019;7(2):165-171.
  6. Behera SK, Das S, Chengappa KG, Xavier AS, Selvarajan S. Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity. Curr Clin Pharmacol. 2019;14(2):84-90.
  7. Behera SK, Selvarajan S, Mathews J, Shajil C, Das S, Munisamy M, Xavier AS. A Novel Desensitization Protocol for Infliximab Hypersensitivity in a 13-Year Old Patient with Pustular Psoriasis. Curr Drug Saf. 2019;14(2):158-162.
  8. Vaidyanathan S, Subramanian K, Bharadwaj B, Das S, Kola GST, Maroju NK. Acute Necrotizing Pancreatitis Associated With Orally Disintegrating Formulation of Olanzapine: Implications on Clinical Presentation and Management. J Clin Psychopharmacol. 2019;39(5):519-521.
  9. Fernandez-Llimos F; Pharmacy Practice 2018 peer reviewers (Das S). Peer review and publication delay. Peer review and publication delay. Pharm Pract (Granada). 2019;17(1):1502.

2018

  1. Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018;40(4):903-910.
  2. Das S, Behera SK, Xavier AS, Velupula S, Dkhar SA, Selvarajan S. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury. Clin Drug Investig. 2018;38(3):211-218.
  3. Ramasamy A, Jothivel N, Das S, Swapna A, Albert AP, Barnwal P, Babu D. Evaluation of the Protective Role of Glycine max Seed Extract (Soybean Oil) in Drug-Induced Nephrotoxicity in Experimental Rats. J Diet Suppl. 2018;15(5):583-595.
  4. Das S, Behera SK, Srinivasan A, Xavier AS, Selvarajan S, Kamalanathan S, Sahoo JP, Nair NS. Effect of metformin on exercise capacity: A meta-analysis. Diabetes Res Clin Pract. 2018;144:270-278.
  5. Das S,* Dey JK, Sen S, Mukherjee R. Efficacy and Safety of Patiromer in Hyperkalemia: A Systematic Review and Meta-Analysis. J Pharm Pract. 2018;31(1):6-17.
  6. Behera SK, Das S, Xavier AS, Selvarajan S. DRESS syndrome: a detailed insigxe5;#xe5;et="_blank" href="https://www.tandfonline.com/doi/abs/10.1080/21548331.2018.1451205?journalCode=ihop20"> Hosp Pract (1995). 2018;46(3):152-162.
  7. Das S,* Barnwal P. The need to train uncertified rural practitioners in India. J Int Med Res. 2018;46(1):522-525. 

2017

  1. Das Adhikari D, Das S, Winston A B, Vazhudhi K, Kumar A, Shanthi Fx M, Agarwal I. A retrospective study on non-drug related poisoning in the community among children from south India. Hosp Pract (1995). 2017;45(2):39-45.
  2. Ambat A, Durai AK, Das S,* Kumar A, Winston AB, Shanthi Fx M. Estimation of actual strengths of different brands of commonly available paracetamol tablets in India and comparing them with the corresponding label information. J Pharmacy Pract Res. 2017;47(2):166-167.
  3. Winston A B, Das Adhikari D, Das S, Vazhudhi K, Kumar A, Shanthi Fx M, Agarwal I. Drug poisoning in the community among children: a nine years' experience from a tertiary care center in south India. Hosp Pract (1995). 2017;45(1):21-27.
  4. Das S, Fleming DH, Mathew BS, Winston A B, Prabhakar AT, Alexander M. Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings. Hosp Pract (1995). 2017;45(2):46-50.
  5. Bandyopadhyay S, Das S,* Mondal S. An Epidemiological Study on the Awareness and Attitude of the Youths Toward AIDS in a Rural Area of West Bengal in India. J Int Assoc Provid AIDS Care. 2017;16(3):290-295. 
  6. Das S,* Barnwal P, Maiti T, Ramasamy A, Mondal S, Babu D. Addiction to Snake Venom. Subst Use Misuse. 2017;52(8):1104-1109.
  7. Barnwal P, Das S,* Mondal S, Ramasamy A, Maiti T, Saha A. Probuphine® (buprenorphine implant): a promising candidate in opioid dependence. Ther Adv Psychopharmacol. 2017;7(3):119-134.

2016

  1. Das S,* Datta A, Bagchi C, Chakraborty S, Mitra A, Tripathi SK. A Comparative Study of Lipid-Lowering Effects of Guggul and Atorvastatin Monotherapy in Comparison to Their Combination in High Cholesterol Diet-Induced Hyperlipidemia in Rabbits. J Diet Suppl. 2016;13(5):495-504.
  2. Das S,* Winston A B, Sukumaran D, Kumar A, Fx MS, Prasad J. Drug prescribing pattern in pregnancy in a secondary care hospital in south India: a retrospective study. Trop Doct. 2016;46(2):86-90.
  3. Sukumaran D, Cherian AG, Das S,* Winston A B, Kumar A, Shanthi Fx M. Drug Prescribing Pattern During Intranatal Period in a Secondary Care Hospital in South India: A Retrospective Study. J Prim Care Community Health. 2016;7(2):113-117.
  4. Saha A, Shanthi F X M, Winston A B, Das S,* Kumar A, Michael JS, Balamugesh T. Prevalence of Hepatotoxicity From Antituberculosis Therapy: A Five-Year Experience From South India. J Prim Care Community Health. 2016;7(3):171-174.
  5. Sen S, Thomas A, Das S, Dey JK, Peedicayil A, Thomas V, Peedicayil J. Inhibition by tadalafil of contractility of isolated nonpregnant human myometrium. J Pharmacol Pharmacother. 2016;7(4):177-181.
  6. Ramasamy A, Das S, Mani V, Sengottuvelu S, Vinoth Prabhu V. Evaluation of Anti-diarrheal Potential of Hydro-alcoholic Extracts of Leaves of Murraya koenigii in Experimental Animals. J Diet Suppl. 2016;13(4):393-401.
  7. Prabhu VV, Sathyamurthy D, Ramasamy A, Das S, Anuradha M, Pachiappan S. Evaluation of protective effects of diosmin (a citrus flavonoid) in chemical-induced urolithiasis in experimental rats. Pharm Biol. 2016;54(9):1513-1521.
  8. Margaret SF, Blessed WA, Kumar A, Das S, Sen S, Ranjalkar J, Sukumaran D. Evaluation of Efficacy of Tutorials in Pharmacology for 2nd year undergraduate Medical Students in India. Res J Phar Tech. 2016;9(2):153-156.
  9. Das S,* Barnwal P, Winston A B, Mondal S, Saha I. Brexpiprazole: so far so good. Ther Adv Psychopharmacolhttps://journals.sagepub.com/doi/10.1177/2045125315614739. 2016;6(1):39-54.
  10. Das S,* Barnwal P, Ramasamy A, Sen S, Mondal S. Lysergic acid diethylamide: a drug of 'use'? Ther Adv Psychopharmacol. 2016;6(3):214-28.
  11. Das S, Ramasamy A, De S, Mondal S. An unusual case of glipizide-induced proximal myopathy. J Pharmacol Pharmacother. 2016;7(2):99-101.

2015

  1. Das S, Bandyopadhyay S, Ramasamy A, Mondal S. Evaluation of hepatoprotective activity of aqueous extracts of leaves of Basella alba in albino rats. Nat Prod Res. 2015;29(11):1059-1064.
  2. Das S, Bandyopadhyay S, Ramasamy A, Prabhu VV, Pachiappan S. A case of losartan-induced severe hyponatremia. J Pharmacol Pharmacother. 2015;6(4):219-221.
     

2014

  1. Ghosh S, Bandyopadhyay S, Bhattacharya S, Misra R, Das S. Quality of life of older people in an urban slum of India. Psychogeriatrics. 2014;14(4):241-246.
  2. Bandyopadhyay S, Das S,* Mondal S. Assessment of Undernutrition Among the Under-5 Children in a Slum of Kolkata: A Comparison Between z Scores and the Conventional System. Childhood Obes Nutr. 2014;6(1):52-57.
  3. Moitra S, Sen S, Datta A, Das S*, Das P, Biswas S, Bandyopadhyay S. Study of Allergenicity Spectrum to Aero Allergens by Skin Prick Testing. Austin J Allergy. 2014;1(1):4.
  4. Choudhury SR, Datta A, Chanda S, Pathak AN, Das S. Overview of current and upcoming strategies implied for the therapy of type 2 diabetes mellitus. Curr Diab275-282.

2013

  1. Datta A, Bagchi C, Das S, Mitra A, Pati AD, Tripathi SK. Antidiabetic and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat models. J Ayurveda Integr Med. 2013;4(2):99-106
  2. Mondal S, Saha I, Das S, Ganguly A, Das D, Tripathi SK. A new logical insight and putative mechanism behind fluoxetine-induced amenorrhea, hyperprolactinemia and galactorrhea in a case series. Ther Adv Psychopharmacol. 2013;3(6):322-334
  3. Das S,* Mondal S, Datta A, Bandyopadhyay S. A rare case of dicyclomine abuse. J Young Pharm. 2013;5(3):106-107.
  4. Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK. A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis. Das S, et al. J Young Pharm. 2013;5(2):64-66.
  5. Mondal S, Das S, Bandopadhyay S, Datta A, Sardar S, Ghosal PK, Tripathi SK. Hepatotoxicity of atenolol therapy - A report of 2 cases. J Acute Dis. 2013;2(3):246-249.
  6. Das S, Saha I, Mondal S, Bandyopadhyay S. Nasal congestion with iloperidone therapy in a case series. Das S, et al.J Young Pharm. 2013;5(3):108-109.

2012

  1. Das S,* Mondal S. Oral levofloxacin-induced optic neuritis progressing in loss of vision. Ther Drug Monit. 2012;34(2):124-125.
  2. Das S,* Ganguly A, Ghosh A, Mondal S, Dey JK, Saha I. Oral pantoprazole-induced acute pancreatitis in an 11-year-old child. Ther Drug Monit. 2012;34(3):242-244
  3. Mondal S, Saha I, Das S,* Ganguly A, Ghosh A, Kumar Das A. Oral aripiprazole-induced severe hypoglycemia. Ther Drug Monit. 2012;34(3):245-248.
  4. Das S,* Mondal S, Dey JK. Roxithromycin-induced toxic epidermal necrolysis. Ther Drug Monit. 2012;34(4):359-362.
  5. Ganguly A, Das S, Dey JK, Mondal S. Clostridium difficile bacteremia and meningitis as a complication of prolonged cephalosporin therapy in a case of staphylococcal pyogenic arthritis. J Acute Dis. 2012;1(2):159-161.
  6. Das S,* Mondal S. Tetanus Toxoid Induced Anaphylaxis. J Vaccines Vaccination. 2012;3(1).

2011

  1.  Das S, Datta A, Das S, Roychowdhury P, Dey (Pati) A, Tripathi SK.Using albino rats in your experiment? Make sure they are healthy. Pharmbit. 2011;XXIII & XXIV(1&2):40-42.

Book Chapters

  1. Das S. How to Compose a Cover Letter and What are the Documents to be Uploaded along with the Manuscript? In: Nandini Chatterjee ed. The Art of Scientific Publication - Do's and Don'ts for Beginners. Chapter 16. Jaypee Brothers; 2024.
  2. Das S. How to Respond to Reviewer Queries? In: Nandini Chatterjee ed. The Art of Scientific Publication - Do's and Don'ts for Beginners. Chapter 17. Jaypee Brothers; 2024. 
  3. Samajdar SS, Sarkar S, Das S, Joshi SR. Hypoglycemia. In: Pal J, Chatterjee N eds. General Practice: An Approach to Differential Diagnosis. Chapter 100. Jaypee Brothers; 2024. 
  4. Dey J, Das S, Samajdar SS. Therapeutic Range of Some Drugs in Respiratory Medicine. In: Pal J, Sarkar S, Chakraborty S eds. Drugs in Respiratory Medicine. 1st Edition, Chapter 26. Jaypee Brothers; 2024.
  5. Venkatraman S, Das S, Samajdar SS. Antimycobacterial Agents. In: Pal J, Chatterjee N eds. Antibiotics: An Integrated Approach. Knowledge Bridge Pvt. Ltd.; 2023 (In Press). 
  6. Mukherjee A, Das S. Antituberculosis Drugs: Pharmacokinetics. In: Lodha R, Kabra SK, Seth V, eds. Essentials of Tuberculosis in Children. 5th Edition, Chapter 30. Jaypee Brothers; 2023.
  7. Das S. Real-World Evidence Studies and Pragmatic Clinical Trials. In: Arivazhahan A, Shah NJ, Selvarajan S, Raj GM, eds. Introduction to Basics of Pharmacology and Toxicology; Pharmacology and Therapeutics, Volume 4. Springer-Nature; 2020 (In Press).